UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Validation of the Bowel Function Index to detect clinically meaningful changes in opioid-induced constipation

Journal of medical economics, 2009-12, Vol.12 (4), p.371-383

2009

Volltextzugriff (PDF)

The Bowel Function Index for Evaluating Constipation in Pain Patients: Definition of a Reference Range for a Non-Constipated Population of Pain Patients

Journal of international medical research, 2011-02, Vol.39 (1), p.41-50

2011

Volltextzugriff (PDF)

A randomised controlled trial assessing the efficacy and safety of repeated tegaserod therapy in women with irritable bowel syndrome with constipation

Gut, 2005-12, Vol.54 (12), p.1707-1713

2005

Volltextzugriff (PDF)

A prematurely terminated journey

Gut, 2011-05, Vol.60 (5), p.630-630

2011

Volltextzugriff (PDF)

Systematic review: cardiovascular safety profile of 5-HT4 agonists developed for gastrointestinal disorders

Alimentary pharmacology & therapeutics, 2012-04, Vol.35 (7), p.745-767

2012

Volltextzugriff (PDF)

Diagnosis and treatment of chronic constipation – a European perspective

Neurogastroenterology and motility, 2011-08, Vol.23 (8), p.697-710

2011

Volltextzugriff (PDF)

Functional bowel disorders and functional abdominal pain

Gut, 1999-09, Vol.45 (suppl 2), p.II43-ii47

1999

Volltextzugriff (PDF)

Levels of satisfaction with current chronic constipation treatment options in Europe – an internet survey

Alimentary pharmacology & therapeutics, 2013-01, Vol.37 (1), p.137-145

2013

Volltextzugriff (PDF)

A double‐blind, placebo‐controlled study of prucalopride in elderly patients with chronic constipation

Neurogastroenterology and motility, 2010-09, Vol.22 (9), p.991-e255

2010

Volltextzugriff (PDF)

Tegaserod, a 5‐HT4 receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation

Alimentary pharmacology & therapeutics, 2001-10, Vol.15 (10), p.1655-1666

2001

Volltextzugriff (PDF)

Fixed-ratio combination oxycodone/naloxone compared with oxycodone alone for the relief of opioid-induced constipation in moderate-to-severe noncancer pain

Current medical research and opinion, 2008-12, Vol.24 (12), p.3503-3512

2008

Volltextzugriff (PDF)

A mixture of Escherichia coli (DSM 17252) and Enterococcus faecalis (DSM 16440) for treatment of the irritable bowel syndrome – A randomized controlled trial with primary care physicians

Neurogastroenterology and motility, 2008-10, Vol.20 (10), p.1103-1109

2008

Volltextzugriff (PDF)

The rise and fall in primary liver cancer mortality in Italy

Digestive and liver disease, 2002-08, Vol.34 (8), p.606-606

2002

Volltextzugriff (PDF)

Systematic review: cardiovascular safety profile of 5‐ HT 4 agonists developed for gastrointestinal disorders

Alimentary pharmacology & therapeutics, 2012-04, Vol.35 (7), p.745-767

2012

Volltextzugriff (PDF)

Is the distinction between organic and functional disorders helpful?

Digestive and liver disease, 2000, Vol.32 (1), p.9-11

Müller-Lissner, S.

2000

Volltextzugriff (PDF)

Contemporary understanding and management of reflux and constipation in the general population and pregnancy: a consensus meeting

Alimentary pharmacology & therapeutics, 2003-08, Vol.18 (3), p.291-301

2003

Volltextzugriff (PDF)

Adverse effects of laxatives: fact and fiction

Pharmacology, 1993-10, Vol.47 Suppl 1 (1), p.138-145

Müller-Lissner, S A

1993

Volltextzugriff (PDF)

Subject's Global Assessment of Relief: An appropriate method to assess the impact of treatment on irritable bowel syndrome-related symptoms in clinical trials

Journal of clinical epidemiology, 2003-04, Vol.56 (4), p.310-316

2003

Volltextzugriff (PDF)

Tegaserod is effective in the initial and retreatment of irritable bowel syndrome with constipation

Alimentary pharmacology & therapeutics, 2005-01, Vol.21 (1), p.11-20

2005

Volltextzugriff (PDF)

Opioid-Induced Constipation and Bowel Dysfunction: A Clinical Guideline

Pain medicine (Malden, Mass.), 2017-10, Vol.18 (10), p.1837-1863

2017

Volltextzugriff (PDF)

Epidemiological Aspects of Irritable Bowel Syndrome in Europe and North America

Digestion, 2001-01, Vol.64 (3), p.200-204

2001

Volltextzugriff (PDF)

Potential Pitfalls in the Differential Diagnosis of Irritable Bowel Syndrome

Digestion, 2000-01, Vol.61 (4), p.247-256

2000

Volltextzugriff (PDF)

Healthy controls have as much bile reflux as gastric ulcer patients

Gut, 1987-12, Vol.28 (12), p.1577-1583

1987

Volltextzugriff (PDF)

Diagnostic value of histology in non-erosive gastro-oesophageal reflux disease

Gut, 1996-08, Vol.39 (2), p.151-154

1996

Volltextzugriff (PDF)

Nongastrointestinal Disorders in the Irritable Bowel Syndrome

Digestion, 2000-01, Vol.62 (1), p.66-72

2000

Volltextzugriff (PDF)

1 – 25 von 306

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(239)
Mit Volltextzugriff
(136)

Publikationsform

Sprache

Englisch
(186)
Deutsch
(119)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(193)
Life Sciences & Biomedicine
(140)
Science & Technology
(140)
Gastroenterology & Hepatology
(107)
Female
(87)
Male
(79)
Biological And Medical Sciences
(74)
Medical Sciences
(72)
Adult
(65)
Middle Aged
(63)
Gastroenterology. Liver. Pancreas. Abdomen
(51)
Other Diseases. Semiology
(47)
Aged
(43)
Stomach. Duodenum. Small Intestine. Colon. Rectum. Anus
(42)
Chronic Disease
(25)
Constipation
(24)
Constipation - Drug Therapy
(24)
Double-Blind Method
(24)
Constipation - Physiopathology
(21)
Irritable Bowel Syndrome
(21)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Validation of the Bowel Function Index to detect clinically meaningful changes in opioid-induced constipation

The Bowel Function Index for Evaluating Constipation in Pain Patients: Definition of a Reference Range for a Non-Constipated Population of Pain Patients

A randomised controlled trial assessing the efficacy and safety of repeated tegaserod therapy in women with irritable bowel syndrome with constipation

A prematurely terminated journey

Systematic review: cardiovascular safety profile of 5-HT4 agonists developed for gastrointestinal disorders

Diagnosis and treatment of chronic constipation – a European perspective

Functional bowel disorders and functional abdominal pain

Levels of satisfaction with current chronic constipation treatment options in Europe – an internet survey

A double‐blind, placebo‐controlled study of prucalopride in elderly patients with chronic constipation

Tegaserod, a 5‐HT4 receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation

Fixed-ratio combination oxycodone/naloxone compared with oxycodone alone for the relief of opioid-induced constipation in moderate-to-severe noncancer pain

A mixture of Escherichia coli (DSM 17252) and Enterococcus faecalis (DSM 16440) for treatment of the irritable bowel syndrome – A randomized controlled trial with primary care physicians

The rise and fall in primary liver cancer mortality in Italy

Systematic review: cardiovascular safety profile of 5‐ HT 4 agonists developed for gastrointestinal disorders

Is the distinction between organic and functional disorders helpful?

Contemporary understanding and management of reflux and constipation in the general population and pregnancy: a consensus meeting

Adverse effects of laxatives: fact and fiction

Subject's Global Assessment of Relief: An appropriate method to assess the impact of treatment on irritable bowel syndrome-related symptoms in clinical trials

Tegaserod is effective in the initial and retreatment of irritable bowel syndrome with constipation

Opioid-Induced Constipation and Bowel Dysfunction: A Clinical Guideline

Epidemiological Aspects of Irritable Bowel Syndrome in Europe and North America

Potential Pitfalls in the Differential Diagnosis of Irritable Bowel Syndrome

Healthy controls have as much bile reflux as gastric ulcer patients

Diagnostic value of histology in non-erosive gastro-oesophageal reflux disease

Nongastrointestinal Disorders in the Irritable Bowel Syndrome

Suchergebnisse filtern